Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

404142434445464748

TOP NEWS: AstraZeneca receives host of EU approvals or recommendations

19th Dec 2022 09:46

(Alliance News) - AstraZeneca PLC on Monday said it received a host of approvals or recommendations for approval for a handful of prospective treatments in the EU, but noted disappointing phase 3 trial results for Imfinzi. Read More

LONDON MARKET OPEN: Stocks higher as China begins shaky reopening

19th Dec 2022 08:55

(Alliance News) - Stock prices in London opened higher on Monday, but the FTSE 100 was lagging behind European counterparts, despite gains for oil and mining stocks. Read More

LONDON BRIEFING: Stocks called up, but prospect of Santa rally fades

19th Dec 2022 07:52

(Alliance News) - The FTSE 100 index looked set to regain some lost ground early on Monday, having fallen to a four-week low last week. Read More

HealthBeacon appoints new interim CFO, permanent CFO process ongoing

16th Dec 2022 10:27

(Alliance News) - HealthBeacon PLC on Friday said it appointed a new interim chief financial officer, while the process to appoint a CFO on a permanent basis is ongoing. Read More

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership

15th Dec 2022 12:13

(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner programme with AstraZeneca PLC. Read More

LONDON BROKER RATINGS: Goldman Sachs likes Big Yellow, Great Portland

15th Dec 2022 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

AstraZeneca and Merck receive US FDA extension for Lynparza review

15th Dec 2022 08:37

(Alliance News) - AstraZeneca PLC on Thursday alongside US peer Merck & Co, announced that the US Food & Drug Administration will extend the Prescription Drug User Fee Act date by three months to allow further time for a full review of the supplementary new drug application of Lynparza in combination with abiraterone and prednisone or prednisolone. Read More

LONDON BRIEFING: Lower open ahead of BoE, ECB; Currys swings to loss

15th Dec 2022 07:49

(Alliance News) - Stock prices in London are set to open lower on Thursday, after the US Federal Reserve raised interest rates as expected and ahead of three more central bank decisions. Read More

LONDON BROKER RATINGS: JPMorgan lowers opinion on UK housebuilders

14th Dec 2022 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

Daiichi and AstraZeneca hail promising breast cancer treatment results

9th Dec 2022 14:24

(Alliance News) - Daiichi Sankyo Co Ltd on Friday said updated results from a phase 1 trial showed datopotamab deruxtecan continued to show promising responses in patients with breast cancer. Read More

CORRECT: AstraZeneca cancer drug shows encouraging results in trial

9th Dec 2022 08:51

(Correcting date of announcement to Thursday.) Read More

AstraZeneca cancer drug shows encouraging results in phase 1 trial

9th Dec 2022 08:43

(Alliance News) - AstraZeneca PLC on Friday announced that datopotamab deruxtecan has shown "encouraging and durable efficacy" in phase 1 trials. Read More

TOP NEWS: AstraZeneca hails breast cancer drug trial results

8th Dec 2022 14:37

(Alliance News) - AstraZeneca PLC on Thursday releases results from trials on its breast cancer drugs camizestrant and capivasertib, both when compared to faslodex, which treats breast cancer. Read More

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

7th Dec 2022 17:25

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More

TOP NEWS: AstraZeneca's Enhertu lowers death risk in breast cancer

7th Dec 2022 14:37

(Alliance News) - AstraZeneca PLC on Wednesday said its Enhertu drug achieved statistically significant overall survival in breast cancer patients in a recent trial. Read More

LONDON MARKET MIDDAY: Stocks slide amid risk-off mood after China data

7th Dec 2022 12:15

(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks. Read More

LONDON MARKET OPEN: Pharmaceutical stocks led by GSK spare FTSE 100

7th Dec 2022 09:02

(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains for pharmaceuticals as GSK shook off Zantac litigation. Read More

LONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSK

5th Dec 2022 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

TOP NEWS: AstraZeneca sells Ohio manufacturing site

30th Nov 2022 09:19

(Alliance News) - AstraZeneca PLC on Wednesday announced the sale of its West Chester manufacturing site in the US state of Ohio to National Resilience Inc. Read More

TOP NEWS: AstraZeneca to buy Neogene for cancer treatment

29th Nov 2022 09:05

(Alliance News) - AstraZeneca PLC said it agreed to buy Neogene Therapeutics Inc for the treatment of cancer, as also noted by healthcare company Syncona Ltd on Tuesday. Read More

404142434445464748
FTSE 100 Latest
Value10,585.91
Change61.15